2f:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/1855-ogyi8eh4.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/25a3ozcrvi1ff.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2lxntcm3pd1_h.js","/_next/static/immutable/chunks/00dgco8irq3jw.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 30:T853,Amblyopia is the leading cause of monocular decreased best-corrected vision in children. Early detection and intervention are key for optimal treatment outcomes; however, limited access to pediatric eye specialists may hinder timely care and affect visual outcomes. Given the shortage of specialty-trained eye care professionals in the US, there is need to support comprehensive eye care professionals who are willing to examine and treat children with amblyopia. A panel from the Pediatric Eye Disease Investigator Group synthesized relevant literature and incorporated consensus opinion where direct evidence was lacking to create the Amblyopia Navigator Decision-Support Instrument, a free, web-based amblyopia decision support tool for eye care professionals. The decisions related to optimal diagnostic measures, pass/refer criteria, and management recommendations were informed by 147 publications. In areas where direct evidence was lacking, guidance was supplemented with clinical trial protocols or existing professional guidelines. When data were conflicting or unavailable, recommendations were established through committee consensus. A single reviewer independently performed standardized (though not systematic) literature reviews to avoid missing pertinent recent publications. Presented are the process used, supporting evidence, and recommendations for testing methods, refractive correction, amblyopia treatment options, treatment adjustments, and monitoring schedules. Because amblyopia is common and typically responds well to treatment, decision support tools that optimize its management could increase access to pediatric eye care by facilitating earlier detection, enabling broader participation of primary eye care professionals, and ultimately improving visual outcomes. Through this work and the development of the forthcoming free, web-based application version, Amblyopia Navigator Decision-Support Instrument, the Pediatric Eye Disease Investigator Group has created decision support tools designed to assist optometrists and ophthalmologists in the care of children aged 3 to 17 years with amblyopia.31:Tbae, Importance Amblyopia is the leading cause of monocular decreased best-corrected vision in children. Early detection and intervention are key for optimal treatment outcomes; however, limited access to pediatric eye specialists may hinder timely care and affect visual outcomes. Given the shortage of specialty-trained eye care professionals in the US, there is need to support comprehensive eye care professionals who are willing to examine and treat children with amblyopia. Objective A panel from the Pediatric Eye Disease Investigator Group synthesized relevant literature and incorporated consensus opinion where direct evidence was lacking to create the Amblyopia Navigator Decision-Support Instrument, a free, web-based amblyopia decision support tool for eye care professionals. Evidence Review The decisions related to optimal diagnostic measures, pass/refer criteria, and management recommendations were informed by 147 publications. In areas where direct evidence was lacking, guidance was supplemented with clinical trial protocols or existing professional guidelines. When data were conflicting or unavailable, recommendations were established through committee consensus. A single reviewer independently performed standardized (though not systematic) literature reviews to avoid missing pertinent recent publications. Findings Presented are the process used, supporting evidence, and recommendations for testing methods, refractive correction, amblyopia treatment options, treatment adjustments, and monitoring schedules. Conclusions and Relevance Because amblyopia is common and typically responds well to treatment, decision support tools that optimize its management could increase access to pediatric eye care by facilitating earlier detection, enabling broader participation of primary eye care professionals, and ultimately improving visual outcomes. Through this work and the development of the forthcoming free, web-based application version, Amblyopia Navigator Decision-Support Instrument, the Pediatric Eye Disease Investigator Group has created decision support tools designed to assist optometrists and ophthalmologists in the care of children aged 3 to 17 years with amblyopia. 25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"Occlusion Therapy: modality Research & Clinical Takeaways\",\"description\":\"Explore peer-reviewed papers on Occlusion Therapy (modality). Clinician-written summaries and actionable practice insights. Updated daily.\",\"url\":\"https://www.reachrx.ai/hub/tag/modality/Occlusion%20Therapy\",\"breadcrumb\":{\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://www.reachrx.ai\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Hub\",\"item\":\"https://www.reachrx.ai/hub\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Modalities\",\"item\":\"https://www.reachrx.ai/hub/tag/modality\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Occlusion Therapy\",\"item\":\"https://www.reachrx.ai/hub/tag/modality/Occlusion%20Therapy\"}]}}"}}]],["$","$L2f",null,{"title":"Occlusion Therapy: Research & Clinical Takeaways","description":"Review evidence by treatment modality: Occlusion Therapy — concise summaries and practical next steps.","papers":[{"doi":"10.1001/jamaophthalmol.2026.1095","pmid":"42096234","title":"Web-Based Amblyopia Decision Support Tool","journal_title":"JAMA Ophthalmology","journal_issn":"2168-6165","published_at":"2026-05-07T00:00:00.000Z","url":"https://doi.org/10.1001/jamaophthalmol.2026.1095","source_score":14,"is_retracted":false,"is_open_access":false,"raw_metadata":{"ooir":{"day":"2026-05-11","doi":"10.1001/jamaophthalmol.2026.1095","days":"7","issn":"2168-6165","rank":"3","field":"Clinical Medicine","score":"14","category":"Ophthalmology","categories":["Ophthalmology"],"_categories":["Ophthalmology"]},"pubmed":{"doi":"10.1001/jamaophthalmol.2026.1095","title":"Web-Based Amblyopia Decision Support Tool.","journal":"JAMA ophthalmology","methods":"","results":"","abstract":"$30","keywords":[],"pubmed_id":"42096234","conclusions":"","publication_date":"2026-05-07T00:00:00"},"crossref":{"DOI":"10.1001/jamaophthalmol.2026.1095","URL":"https://doi.org/10.1001/jamaophthalmol.2026.1095","ISSN":["2168-6165"],"link":[{"URL":"https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2848367/jamaophthalmology_summers_2026_sc_260001_1776890873.53051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":null,"type":"journal-article","issue":null,"score":1,"title":["Web-Based Amblyopia Decision Support Tool"],"author":[{"given":"Allison I.","family":"Summers","sequence":"first","affiliation":[{"name":"Oregon Health & Science University, Casey Eye Institute, Portland"}]},{"given":"Stanley W.","family":"Hatch","sequence":"additional","affiliation":[{"name":"Pennsylvania College of Optometry, Drexel University, Philadelphia"}]},{"given":"Sarah R.","family":"Hatt","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}]},{"given":"Emily K.","family":"Wiecek","sequence":"additional","affiliation":[{"name":"Boston Children’s Hospital, Boston, Massachusetts"}]},{"given":"Michelle R.","family":"Hribar","sequence":"additional","affiliation":[{"name":"Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago"}]},{"given":"Julianne L.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}]},{"given":"Angela M.","family":"Chen","sequence":"additional","affiliation":[{"name":"Southern California College of Optometry at Marshall B. Ketchum University, Fullerton"}]},{"given":"Marjean T.","family":"Kulp","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Optometry, Columbus"}]},{"given":"Debora M. Lee","family":"Chen","sequence":"additional","affiliation":[{"name":"Herbert Wertheim School of Optometry and Vision Science, University of California, Berkeley"}]},{"given":"Michael X.","family":"Repka","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland"}]},{"given":"Jingyun","family":"Wang","sequence":"additional","affiliation":[{"name":"State University of New York, College of Optometry, New York"}]},{"given":"Tawna L.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Spencer Center for Vision Research, Byers Eye Institute at Stanford University, Palo Alto, California"}]},{"given":"David K.","family":"Wallace","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}]},{"given":"Marilyn","family":"Vricella","sequence":"additional","affiliation":[{"name":"State University of New York, College of Optometry, New York"}]},{"given":"Steven","family":"Chang","sequence":"additional","affiliation":[{"name":"Southern California College of Optometry at Marshall B. Ketchum University, Fullerton"}]},{"given":"Kathleen M.","family":"Stutz","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}]},{"given":"Wesley T.","family":"Beaulieu","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}]},{"given":"Raymond T.","family":"Kraker","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}]},{"given":"Susan A.","family":"Cotter","sequence":"additional","affiliation":[{"name":"Southern California College of Optometry at Marshall B. Ketchum University, Fullerton"}]},{"given":"Jonathan M.","family":"Holmes","sequence":"additional","affiliation":[{"name":"University of Arizona, Tucson"}]},{"given":"Katherine K.","family":"Weise","sequence":"additional","affiliation":[{"name":"School of Optometry, University of Alabama, Birmingham"}]},{"given":"Stacy L.","family":"Pineles","sequence":"additional","affiliation":[{"name":"Jules Stein Institute at the University of California, Los Angeles"}]},{"given":null,"family":null,"sequence":"additional","affiliation":[]}],"issued":{"date-parts":[[2026,5,7]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":null,"created":{"date-time":"2026-05-07T15:30:38Z","timestamp":1778167838000,"date-parts":[[2026,5,7]]},"indexed":{"date-time":"2026-05-07T16:16:02Z","timestamp":1778170562915,"date-parts":[[2026,5,7]]},"subject":[],"abstract":"$31","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2848367"}},"subtitle":[],"deposited":{"date-time":"2026-05-07T15:30:40Z","timestamp":1778167840000,"date-parts":[[2026,5,7]]},"issn-type":[{"type":"print","value":"2168-6165"}],"published":{"date-parts":[[2026,5,7]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1016/j.ophtha.2022.11.003","key":"esc260001r1","year":"2023","issue":"3","author":"Cruz","volume":"130","first-page":"136","unstructured":null,"article-title":"Amblyopia preferred practice pattern.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.preteyeres.2012.11.001","key":"esc260001r2","year":"2013","issue":null,"author":"Birch","volume":"33","first-page":"67","unstructured":null,"article-title":"Amblyopia and binocular vision.","journal-title":"Prog Retin Eye Res","doi-asserted-by":"publisher"},{"DOI":"10.22336/rjo.2020.56","key":"esc260001r3","year":"2020","issue":"4","author":"Mostafaie","volume":"64","first-page":"342","unstructured":null,"article-title":"A systematic review of Amblyopia prevalence among the children of the world.","journal-title":"Rom J Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1136/bjophthalmol-2019-314759","key":"esc260001r4","year":"2020","issue":"8","author":"Fu","volume":"104","first-page":"1164","unstructured":null,"article-title":"Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis.","journal-title":"Br J Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.3928/01913913-20250619-05","key":"esc260001r5","year":"2025","issue":"5","author":"Adhan","volume":"62","first-page":"321","unstructured":null,"article-title":"Analyzing trends in the pediatric ophthalmology workforce from 2016 to 2024.","journal-title":"J Pediatr Ophthalmol Strabismus","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamaophthalmol.2024.0612","key":"esc260001r6","year":"2024","issue":"5","author":"Siegler","volume":"142","first-page":"454","unstructured":null,"article-title":"Access to pediatric eye care by practitioner type, geographic distribution, and US population demographics.","journal-title":"JAMA Ophthalmol","doi-asserted-by":"publisher"},{"DOI":null,"key":"esc260001r7","year":"1985","issue":"11","author":"Birch","volume":"26","first-page":"1624","unstructured":null,"article-title":"Monocular acuity and stereopsis in infantile esotropia.","journal-title":"Invest Ophthalmol Vis Sci","doi-asserted-by":null},{"DOI":"10.1016/j.ophtha.2022.10.030","key":"esc260001r9","year":"2023","issue":"3","author":"Hutchinson","volume":"130","first-page":"222","unstructured":null,"article-title":"Pediatric eye evaluations preferred practice pattern.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ophtha.2011.06.033","key":"esc260001r10","year":"2011","issue":"11","author":"Tarczy-Hornoch","volume":"118","first-page":"2262","unstructured":null,"article-title":"Risk factors for decreased visual acuity in preschool children: the multi-ethnic pediatric eye disease and Baltimore pediatric eye disease studies.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.1016/S0002-9394(01)01256-9","key":"esc260001r12","year":"2001","issue":"6","author":"Moke","volume":"132","first-page":"903","unstructured":null,"article-title":"Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol.","journal-title":"Am J Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1001/archopht.119.9.1345","key":"esc260001r13","year":"2001","issue":"9","author":"Holmes","volume":"119","first-page":"1345","unstructured":null,"article-title":"The amblyopia treatment study visual acuity testing protocol.","journal-title":"Arch Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.3389/fmed.2022.959085","key":"esc260001r14","year":"2022","issue":null,"author":"Chen","volume":"9","first-page":null,"unstructured":null,"article-title":"Refraction development in anisometropic amblyopia with patching therapy.","journal-title":"Front Med (Lausanne)","doi-asserted-by":"publisher"},{"DOI":"10.1097/OPX.0000000000002226","key":"esc260001r15","year":"2025","issue":"3","author":"Bist","volume":"102","first-page":"175","unstructured":null,"article-title":"Comparative efficacy of tropicamide 1% and cyclopentolate 1% for cycloplegic refraction: a systematic review and meta-analysis of randomized controlled trials.","journal-title":"Optom Vis Sci","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.optom.2017.09.001","key":"esc260001r16","year":"2018","issue":"3","author":"Yazdani","volume":"11","first-page":"135","unstructured":null,"article-title":"Comparison of cyclopentolate versus tropicamide cycloplegia: a systematic review and meta-analysis.","journal-title":"J Optom","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.yaoo.2016.03.007","key":"esc260001r17","year":"2016","issue":"1","author":"Chen","volume":"1","first-page":"287","unstructured":null,"article-title":"The amblyopia treatment studies: implications for clinical practice.","journal-title":"Adv Ophthalmol Optom","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamaophthalmol.2021.0082","key":"esc260001r18","year":"2021","issue":"4","author":"Chen","volume":"139","first-page":"464","unstructured":null,"article-title":"Overminus lens therapy for children 3 to 10 years of age with intermittent exotropia: a randomized clinical trial.","journal-title":"JAMA Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ajo.2017.11.017","key":"esc260001r19","year":"2018","issue":null,"author":"Manh","volume":"186","first-page":"104","unstructured":null,"article-title":"A randomized trial of a binocular iPad game versus part-time patching in children aged 13 to 16 years with amblyopia.","journal-title":"Am J Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1001/archopht.120.3.281","key":"esc260001r20","year":"2002","issue":"3","author":"Pediatric Eye Disease Investigator Group","volume":"120","first-page":"281","unstructured":null,"article-title":"The clinical profile of moderate amblyopia in children younger than 7 years.","journal-title":"Arch Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ophtha.2008.06.031","key":"esc260001r21","year":"2008","issue":"11","author":"Pediatric Eye Disease Investigator Group","volume":"115","first-page":"2071","unstructured":null,"article-title":"A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ajo.2007.05.040","key":"esc260001r22","year":"2007","issue":"4","author":"Wallace","volume":"144","first-page":"487","unstructured":null,"article-title":"Treatment of bilateral refractive amblyopia in children three to less than 10 years of age.","journal-title":"Am J Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ajo.2019.10.030","key":"esc260001r23","year":"2020","issue":null,"author":"Shoshany","volume":"211","first-page":"87","unstructured":null,"article-title":"Effect of primary occlusion therapy in asymmetric, bilateral amblyopia.","journal-title":"Am J Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ophtha.2006.01.068","key":"esc260001r24","year":"2006","issue":"6","author":"Cotter","volume":"113","first-page":"895","unstructured":null,"article-title":"Treatment of anisometropic amblyopia in children with refractive correction.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ajo.2007.02.029","key":"esc260001r25","year":"2007","issue":"6","author":"Cotter","volume":"143","first-page":"1060","unstructured":null,"article-title":"Treatment of strabismic amblyopia with refractive correction.","journal-title":"Am J Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1001/archopht.123.4.437","key":"esc260001r26","year":"2005","issue":"4","author":"Scheiman","volume":"123","first-page":"437","unstructured":null,"article-title":"Randomized trial of treatment of amblyopia in children aged 7 to 17 years.","journal-title":"Arch Ophthalmol","doi-asserted-by":"publisher"},{"DOI":null,"key":"esc260001r27","year":"2011","issue":"8","author":"Medghalchi","volume":"13","first-page":"578","unstructured":null,"article-title":"A randomized trial of atropine vs patching for treatment of moderate amblyopia.","journal-title":"Iran Red Crescent Med J","doi-asserted-by":null},{"DOI":"10.1001/archopht.120.3.268","key":"esc260001r28","year":"2002","issue":"3","author":"Pediatric Eye Disease Investigator Group.","volume":"120","first-page":"268","unstructured":null,"article-title":"A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.","journal-title":"Arch Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1001/archopht.121.5.603","key":"esc260001r29","year":"2003","issue":"5","author":"Repka","volume":"121","first-page":"603","unstructured":null,"article-title":"A randomized trial of patching regimens for treatment of moderate amblyopia in children.","journal-title":"Arch Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaapos.2009.03.002","key":"esc260001r30","year":"2009","issue":"3","author":"Repka","volume":"13","first-page":"258","unstructured":null,"article-title":"Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials.","journal-title":"J AAPOS","doi-asserted-by":"publisher"},{"DOI":"10.1016/S0140-6736(23)02893-3","key":"esc260001r31","year":"2024","issue":"10438","author":"Proudlock","volume":"403","first-page":"1766","unstructured":null,"article-title":"Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial.","journal-title":"Lancet","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ophtha.2013.04.008","key":"esc260001r32","year":"2013","issue":"11","author":"Wallace","volume":"120","first-page":"2270","unstructured":null,"article-title":"A randomized trial of increasing patching for amblyopia.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.1001/archophthalmol.2011.174","key":"esc260001r33","year":"2011","issue":"7","author":"Wallace","volume":"129","first-page":"960","unstructured":null,"article-title":"Randomized trial to evaluate combined patching and atropine for residual amblyopia.","journal-title":"Arch Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ophtha.2009.10.014","key":"esc260001r34","year":"2010","issue":"5","author":"Rutstein","volume":"117","first-page":"998","unstructured":null,"article-title":"A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.2147/OPTH.S513329","key":"esc260001r35","year":"2025","issue":null,"author":"Nughays","volume":"19","first-page":"1999","unstructured":null,"article-title":"Efficacy of dichoptic treatment vs eye patching in pediatric patients with amblyopia: a systematic review and meta-analysis of randomized controlled trials.","journal-title":"Clin Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1136/bmjophth-2020-000625","key":"esc260001r36","year":"2021","issue":"1","author":"Chen","volume":"6","first-page":null,"unstructured":null,"article-title":"Comparison between binocular therapy and patching for treatment of amblyopia: a meta-analysis of randomised controlled trials.","journal-title":"BMJ Open Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ophtha.2021.09.001","key":"esc260001r37","year":"2022","issue":"1","author":"Xiao","volume":"129","first-page":"77","unstructured":null,"article-title":"Randomized controlled trial of a dichoptic digital therapeutic for amblyopia.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ajo.2024.08.011","key":"esc260001r38","year":"2025","issue":null,"author":"Wygnanski-Jaffe","volume":"269","first-page":"293","unstructured":null,"article-title":"High-adherence dichoptic treatment versus patching in anisometropic and small angle strabismus amblyopia: a randomized controlled trial.","journal-title":"Am J Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaapos.2003.09.005","key":"esc260001r39","year":"2004","issue":"5","author":"Hussein","volume":"8","first-page":"429","unstructured":null,"article-title":"Risk factors for treatment failure of anisometropic amblyopia.","journal-title":"J AAPOS","doi-asserted-by":"publisher"},{"DOI":null,"key":"esc260001r40","year":"1999","issue":null,"author":"Flynn","volume":"97","first-page":"373","unstructured":null,"article-title":"The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets.","journal-title":"Trans Am Ophthalmol Soc","doi-asserted-by":null},{"DOI":"10.1001/archophthalmol.2011.179","key":"esc260001r41","year":"2011","issue":"11","author":"Holmes","volume":"129","first-page":"1451","unstructured":null,"article-title":"Effect of age on response to amblyopia treatment in children.","journal-title":"Arch Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1038/eye.1994.157","key":"esc260001r42","year":"1994","issue":"Pt 6","author":"Woodruff","volume":"8","first-page":"627","unstructured":null,"article-title":"Factors affecting the outcome of children treated for amblyopia.","journal-title":"Eye (Lond)","doi-asserted-by":"publisher"},{"DOI":"10.1167/iovs.13-11861","key":"esc260001r43","year":"2013","issue":"9","author":"Wallace","volume":"54","first-page":"6158","unstructured":null,"article-title":"Compliance with occlusion therapy for childhood amblyopia.","journal-title":"Invest Ophthalmol Vis Sci","doi-asserted-by":"publisher"},{"DOI":null,"key":"esc260001r44","year":"2025","issue":"7","author":"Chen","volume":"7","first-page":null,"unstructured":null,"article-title":"Interventions for improving adherence to amblyopia treatments in children.","journal-title":"Cochrane Database Syst Rev","doi-asserted-by":null},{"DOI":"10.1016/S1091-8531(04)00161-2","key":"esc260001r45","year":"2004","issue":"5","author":"Holmes","volume":"8","first-page":"420","unstructured":null,"article-title":"Risk of amblyopia recurrence after cessation of treatment.","journal-title":"J AAPOS","doi-asserted-by":"publisher"},{"DOI":"10.1001/archopht.125.5.655","key":"esc260001r46","year":"2007","issue":"5","author":"Hertle","volume":"125","first-page":"655","unstructured":null,"article-title":"Stability of visual acuity improvement following discontinuation of amblyopia treatment in children aged 7 to 12 years.","journal-title":"Arch Ophthalmol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ophtha.2006.11.023","key":"esc260001r47","year":"2007","issue":"8","author":"Holmes","volume":"114","first-page":"1427","unstructured":null,"article-title":"Factors associated with recurrence of amblyopia on cessation of patching.","journal-title":"Ophthalmology","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamaophthalmol.2014.392","key":"esc260001r48","year":"2014","issue":"7","author":"Repka","volume":"132","first-page":"799","unstructured":null,"article-title":"Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.","journal-title":"JAMA Ophthalmol","doi-asserted-by":"publisher"},{"DOI":null,"key":"esc260001r8","year":"1994","issue":null,"author":"American Optometric Association","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"esc260001r11","year":"2003","issue":null,"author":"Deafness WPftPoBa","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Ophthalmology"],"reference-count":48,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2026,5,7]]},"references-count":48,"short-container-title":["JAMA Ophthalmol"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1001/jamaophthalmol.2026.1095","is_oa":false,"title":"Web-Based Amblyopia Decision Support Tool","updated":"2026-05-08T16:02:47+00:00","published_date":"2026-05-07","best_oa_location":null}},"created_at":"2026-05-12T13:18:04.495Z","updated_at":"2026-05-14T15:13:26.918Z","tags":[{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"age_group","value":"pediatric","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"category","value":"Ophthalmology","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"condition","value":"Amblyopia","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"impact_flag","value":"practice_changing","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"level_of_evidence","value":"5","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"modality","value":"Occlusion Therapy","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"modality","value":"Refractive Correction","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"study_design","value":"Clinical Practice Guideline / Decision Support Tool Development","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"warning","value":"No sample size applies — this is a guideline/decision-tool development paper, not a clinical trial with enrolled participants.","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"warning","value":"Study design classification is ambiguous — this paper describes both an expert consensus process and an evidence synthesis, but does not follow a formal systematic review methodology.","value_numeric":null},{"paper_doi":"10.1001/jamaophthalmol.2026.1095","tag_type":"warning","value":"The web-based Amblyopia Navigator application was described as 'forthcoming' at publication; clinicians should verify current availability.","value_numeric":null}],"summaries":{"what_studied":"A Pediatric Eye Disease Investigator Group (PEDIG) expert panel developed the **Amblyopia Navigator Decision-Support Instrument** — a free, web-based clinical tool to guide eye care professionals in diagnosing and managing amblyopia in children aged 3–17 years, informed by 147 publications and consensus opinion where evidence was lacking.","key_result":"The tool provides structured recommendations covering testing methods, refractive correction, treatment options (including treatment adjustments), and monitoring schedules; gaps in direct evidence were bridged by clinical trial protocols, professional guidelines, and committee consensus.","limitations":"- Literature review was performed by a single reviewer using a non-systematic approach, raising risk of selection bias.\n- Recommendations in several areas rely on expert consensus rather than direct trial evidence.\n- The web-based application was forthcoming at time of publication — real-world clinical validation data are not yet available.","practice_takeaway":"Optometrists and ophthalmologists managing children with amblyopia can use the free Amblyopia Navigator Decision-Support Instrument to guide diagnostic and treatment decisions, particularly in settings without ready access to pediatric eye specialists. Early adoption may help extend timely amblyopia care to primary eye care settings."}},{"doi":"10.1016/j.jaapos.2026.104842","pmid":"42035945","title":"Beyond clinical trials: real-world predictors of amblyopia resolution in Saudi Arabian children","journal_title":"Journal of American Association for Pediatric Ophthalmology and Strabismus","journal_issn":"1091-8531","published_at":"2026-04-24T00:00:00.000Z","url":"https://doi.org/10.1016/j.jaapos.2026.104842","source_score":5,"is_retracted":false,"is_open_access":false,"raw_metadata":{"pubmed":true,"crossref":true,"unpaywall":true},"created_at":"2026-05-07T22:49:55.178Z","updated_at":"2026-05-07T22:49:55.178Z","tags":[{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"age_group","value":"child","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"category","value":"Ophthalmology","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"condition","value":"Amblyopia","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"impact_flag","value":"confirms_prior","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"level_of_evidence","value":"4","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"modality","value":"Occlusion Therapy","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"modality","value":"Optical Correction","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"sample_size","value":"n=198","value_numeric":198},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"study_design","value":"Retrospective Cohort Study","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"warning","value":"Compliance data for patching and spectacle wear were not captured, which is a major unmeasured confounder in amblyopia outcomes research.","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"warning","value":"Results are from a single region in Saudi Arabia (Qassim province public hospitals); generalizability to other healthcare systems or ethnic populations is uncertain.","value_numeric":null},{"paper_doi":"10.1016/j.jaapos.2026.104842","tag_type":"warning","value":"The study is retrospective and observational; the apparent inferiority of patching alone vs. glasses alone may reflect indication bias (e.g., more severe or non-compliant cases assigned to patching). Causality should not be assumed.","value_numeric":null}],"summaries":{"limitations":"Retrospective design limits causal inference and introduces selection/documentation bias. Single-region (Qassim province) public hospital sample may not generalize to other settings. Compliance with patching and optical correction was not directly measured.","practice_takeaway":"Start treatment early and prioritize optical correction (glasses); patching alone appears less effective than glasses alone in real-world practice. Ensure continuity of follow-up visits, as attendance is an independent predictor of resolution.","what_studied":"Retrospective review of 198 children aged 3–10 years with unilateral amblyopia (strabismic, anisometropic, or mixed) treated at four public hospitals in Qassim province, Saudi Arabia (2017–2022), evaluating treatment outcomes and predictors of complete resolution (final interocular VA difference ≤0.1 logMAR).","key_result":"50% of children (99/198) achieved complete resolution, with mean proportional improvement of 53.9%. Worse baseline VA reduced odds of resolution (aOR 0.60 per 0.1 logMAR decrement; P<0.001). Patching alone was associated with worse outcomes vs. glasses only (aOR 0.38; P=0.015). More follow-up visits independently predicted success; amblyopia type was not independently associated with resolution."}}],"initialOffset":2,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"modality","value":"Occlusion Therapy"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Modalities","href":"/hub/tag/modality"},{"name":"Occlusion Therapy"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"modality","hub_tag_value":"Occlusion Therapy"}}}]]

Papers